BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33415820)

  • 1. An autopsy report of a familial amyotrophic lateral sclerosis case carrying VCP Arg487His mutation with a unique TDP-43 proteinopathy.
    Matsubara T; Izumi Y; Oda M; Takahashi M; Maruyama H; Miyamoto R; Watanabe C; Tachiyama Y; Morino H; Kawakami H; Saito Y; Murayama S
    Neuropathology; 2021 Apr; 41(2):118-126. PubMed ID: 33415820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An autopsy case of amyotrophic lateral sclerosis with striatonigral and pallidoluysian degeneration and cat's-eye-shaped neuronal nuclear inclusions.
    Kon T; Mori F; Kinoshita I; Nakamura T; Nishijima H; Suzuki C; Goto S; Kijima H; Tomiyama M; Wakabayashi K
    Neuropathology; 2022 Aug; 42(4):329-338. PubMed ID: 35775096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
    Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE
    Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three VCP Mutations in Patients with Frontotemporal Dementia.
    Wong TH; Pottier C; Hondius DC; Meeter LHH; van Rooij JGJ; Melhem S; ; van Minkelen R; van Duijn CM; Rozemuller AJM; Seelaar H; Rademakers R; van Swieten JC
    J Alzheimers Dis; 2018; 65(4):1139-1146. PubMed ID: 30103325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontotemporal dementia (FTD) and genetic mutations including progranulin gene].
    Arai T; Hasegawa M; Nishihara M; Nonaka T; Kametani F; Yoshida M; Hashizume Y; Beach TG; Morita M; Nakano I; Oda T; Tsuchiya K; Akiyama H
    Rinsho Shinkeigaku; 2008 Nov; 48(11):990-3. PubMed ID: 19198141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.
    Kosaka T; Fu YJ; Shiga A; Ishidaira H; Tan CF; Tani T; Koike R; Onodera O; Nishizawa M; Kakita A; Takahashi H
    Neuropathology; 2012 Aug; 32(4):373-84. PubMed ID: 22098653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies.
    Geser F; Lee VM; Trojanowski JQ
    Neuropathology; 2010 Apr; 30(2):103-12. PubMed ID: 20102519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant.
    Ayaki T; Ito H; Fukushima H; Inoue T; Kondo T; Ikemoto A; Asano T; Shodai A; Fujita T; Fukui S; Morino H; Nakano S; Kusaka H; Yamashita H; Ihara M; Matsumoto R; Kawamata J; Urushitani M; Kawakami H; Takahashi R
    Acta Neuropathol Commun; 2014 Dec; 2():172. PubMed ID: 25492614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
    Takeda T
    Neuropathology; 2018 Feb; 38(1):72-81. PubMed ID: 28960544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular dynamics of Ataxin-2 in the human brains with normal and frontotemporal lobar degeneration with TDP-43 inclusions.
    Watanabe R; Higashi S; Nonaka T; Kawakami I; Oshima K; Niizato K; Akiyama H; Yoshida M; Hasegawa M; Arai T
    Acta Neuropathol Commun; 2020 Oct; 8(1):176. PubMed ID: 33115537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dissection of TDP-43 proteinopathies.
    Hasegawa M; Nonaka T; Tsuji H; Tamaoka A; Yamashita M; Kametani F; Yoshida M; Arai T; Akiyama H
    J Mol Neurosci; 2011 Nov; 45(3):480-5. PubMed ID: 21678031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
    Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
    Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valosin-containing protein Asp395Gly mutation in a patient with frontotemporal dementia: a case report.
    Kobayashi R; Naruse H; Kawakatsu S; Iseki C; Suzuki Y; Koyama S; Morioka D; Ishiura H; Mitsui J; Ohta Y; Tsuji S; Toda T; Otani K
    BMC Neurol; 2022 Nov; 22(1):406. PubMed ID: 36329418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease animal models of TDP-43 proteinopathy and their pre-clinical applications.
    Liu YC; Chiang PM; Tsai KJ
    Int J Mol Sci; 2013 Oct; 14(10):20079-111. PubMed ID: 24113586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration.
    Wils H; Kleinberger G; Janssens J; Pereson S; Joris G; Cuijt I; Smits V; Ceuterick-de Groote C; Van Broeckhoven C; Kumar-Singh S
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3858-63. PubMed ID: 20133711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and pathological spectrum of TDP-43 associated ALS].
    Onodera O; Yokoseki A; Tan CF; Ishihara T; Nishiira Y; Toyoshima Y; Kakita A; Nishizawa M; Takahashi H
    Rinsho Shinkeigaku; 2010 Nov; 50(11):940-2. PubMed ID: 21921519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An autopsy case of early-stage amyotrophic lateral sclerosis with TDP-43 immunoreactive neuronal, but not glial, inclusions.
    Kon T; Mori F; Oyama Y; Tanji K; Kimura T; Takahashi S; Wakabayashi K
    Neuropathology; 2019 Jun; 39(3):224-230. PubMed ID: 31020724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and pathological continuum of multisystem TDP-43 proteinopathies.
    Geser F; Martinez-Lage M; Robinson J; Uryu K; Neumann M; Brandmeir NJ; Xie SX; Kwong LK; Elman L; McCluskey L; Clark CM; Malunda J; Miller BL; Zimmerman EA; Qian J; Van Deerlin V; Grossman M; Lee VM; Trojanowski JQ
    Arch Neurol; 2009 Feb; 66(2):180-9. PubMed ID: 19204154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.